Appearance
Dense, frost-coated buds.
Tilray · Indica-dominant· New release
Tilray THC25
Bred by Tilray Medical.
THC23–27% THCCultivationIndoor
Educational reference. Not medical advice. Medical cannabis is a prescription-only medicine in the UK — consult a specialist clinician.
History & Producer
Origin
Premium high-THC release within Tilray's UK catalogue.
Genetics
Lineage
Proprietary high-THC cross
Indica 65%Sativa 35%
Cannabinoid & Production Profile
Specifications
- THC
- 23–27% THC
- CBD
- <1.0%
- Classification
- Indica-dominant
- Cultivation
- Indoor
- Irradiation
- Gamma
Dominant Terpenes
Aromatic Compounds
- Myrcene0.85%Earthy · clove
- β-Caryophyllene0.42%Pepper · spice
- Linalool0.21%Lavender · floral
Sensory Profile
Appearance, Flavour & Aroma
Flavour
Sweet earth, pine, gas.
Aroma
Pine, fuel.
Reported Effects
Effect Profile
Aggregated from patient diaries and prescriber feedback. Intensity is relative within this strain's profile, not an absolute clinical measure.
Relaxed88%
Sleepy82%
Body Heaviness76%
Pain Relief78%
Euphoric58%
Appetite60%
Condition Recommendations
Discussed Indications
Chronic pain
Evidence · Emerging
Myrcene-dominant profile commonly prescribed for nocturnal musculoskeletal and neuropathic pain.
Strong fitInsomnia / sleep maintenance
Evidence · Emerging
Sedating terpene profile typically prescribed as an evening cultivar.
Strong fitTreatment-resistant anxiety
Evidence · Limited
Calming profile may help; high THC unsuitable for THC-naive patients.
Moderate fitDaytime productivity
Evidence · Anecdotal
Sedating profile is generally unsuitable for daytime cognitive demands or driving.
Caution
Not a substitute for a prescriber's assessment. Suitability depends on tolerance, comorbidities and concomitant medication.
More from Tilray
